Article
Role of syndecan-4 in breast cancer pathophysiology
12 Sept 2022
Abstract excerpt
Expression of the cell surface heparan sulfate proteoglycan syndecan-4 is dysregulated in breast cancer, the most frequent malignancy in women. High expression of syndecan-4 correlates with a worse survival in the subgroup of estrogen receptor negative and estrogen/progesterone-receptor negative patients. Aberrant expression of syndecan-4 in breast cancer involves both transcriptional and posttranscriptional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
